Followers | 165 |
Posts | 36588 |
Boards Moderated | 1 |
Alias Born | 10/20/2019 |
Friday, June 02, 2023 12:07:06 PM
$MGRX
Recent MGRX News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 10:04:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 12:00:34 PM
- Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 10/31/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2024 09:00:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/22/2024 12:00:11 PM
- MangoRx Announces Formation of Strategy and Alternatives Committee • GlobeNewswire Inc. • 10/22/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/21/2024 09:10:26 PM
- MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly • GlobeNewswire Inc. • 10/21/2024 09:10:00 PM
- MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN • GlobeNewswire Inc. • 10/11/2024 09:15:00 PM
- MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions • GlobeNewswire Inc. • 10/03/2024 12:30:00 PM
- Healthcare Shares Rise Following Product Availability Announcement • AllPennyStocks.com • 10/01/2024 05:05:00 PM
- MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment • GlobeNewswire Inc. • 10/01/2024 11:30:00 AM
- MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024 • GlobeNewswire Inc. • 08/15/2024 01:25:00 PM
- MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent • GlobeNewswire Inc. • 08/13/2024 08:00:00 PM
- MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide • GlobeNewswire Inc. • 08/09/2024 12:15:00 PM
- MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology • GlobeNewswire Inc. • 07/24/2024 12:15:00 PM
- Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access • GlobeNewswire Inc. • 07/18/2024 08:05:00 PM
- MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts • GlobeNewswire Inc. • 07/16/2024 12:20:00 PM
- MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department • GlobeNewswire Inc. • 07/12/2024 05:30:00 PM
- MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets • GlobeNewswire Inc. • 07/11/2024 12:15:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/18/2024 06:57:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/10/2024 05:28:45 PM
- MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology • GlobeNewswire Inc. • 06/06/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 09:15:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:15:25 PM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM